共 160 条
[1]
DeFronzo RA(2015)Type 2 diabetes mellitus Nat Rev Dis Primers 1 15019-690
[2]
Ferrannini E(2013)The global NAFLD epidemic Nat Rev Gastroenterol Hepatol 10 686-84
[3]
Groop L(2016)Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-307
[4]
Loomba R(2017)Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: a systematic review and meta-analysis PLoS ONE 12 e0176941-1218
[5]
Sanyal AJ(2015)Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease Med Ultrason 17 300-242
[6]
Younossi ZM(2007)Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients Diabetes Care 30 1212-s112
[7]
Koenig AB(2013)Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program Aliment Pharmacol Ther 37 234-2192
[8]
Abdelatif D(2006)Nonalcoholic fatty liver disease: from steatosis to cirrhosis Hepatology 43 S99-1554
[9]
Fazel Y(2019)Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease Future Med Chem 11 2171-1882
[10]
Henry L(2015)Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up Hepatology 61 1547-337